These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1881584)

  • 21. Novel erythropoiesis-stimulating protein in the management of the anemia of chronic renal failure.
    Maxwell AP
    Kidney Int; 2002 Aug; 62(2):720-9. PubMed ID: 12110039
    [No Abstract]   [Full Text] [Related]  

  • 22. Use of recombinant erythropoietin in the treatment of anaemia associated with multiple myeloma in a haemodialysis patient.
    Hussein MM; Mooij JM; Roujouleh H
    Nephrol Dial Transplant; 1994; 9(7):876-7. PubMed ID: 7818713
    [No Abstract]   [Full Text] [Related]  

  • 23. [Recombinant human erythropoietin and chronic kidney failure: current situation and therapeutic implications].
    Romero González R; Torquet Escuder P
    Med Clin (Barc); 1990 Nov; 95(17):656-9. PubMed ID: 2089205
    [No Abstract]   [Full Text] [Related]  

  • 24. Evaluation of changes in amino acid metabolism in pre-dialysis patients treated with erythropoietin.
    Nishikage H; Kosugi T; Danbara A; Yamamoto J; Matsuo S; Hotta N
    Nephron; 2000 Jul; 85(3):277-8. PubMed ID: 10867545
    [No Abstract]   [Full Text] [Related]  

  • 25. Correction of the anemia of end-stage renal disease with recombinant human erythropoietin.
    N Engl J Med; 1987 Jul; 317(4):249-51. PubMed ID: 3600716
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of chronic renal failure anemia by recombinant erythropoietin and polycythemia following kidney transplantation.
    Kessler M; Legrand E; Mertes M; Renoult E; Hestin D
    Nephron; 1992; 62(3):370-1. PubMed ID: 1436359
    [No Abstract]   [Full Text] [Related]  

  • 27. Improvement of anemia and secondary hyperparathyroidism with erythropoietin treatment in hemodialysis patients.
    Seyrek N; Paydas S; Sagliker Y
    Nephron; 1996; 73(2):338-9. PubMed ID: 8773378
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of anemia in renal failure].
    Siciński A
    Pol Tyg Lek; 1974 Nov; 29(44):1895-8. PubMed ID: 4610533
    [No Abstract]   [Full Text] [Related]  

  • 29. Erythropoietin use in pregnancy: two cases and a review of the literature.
    Scott LL; Ramin SM; Richey M; Hanson J; Gilstrap LC
    Am J Perinatol; 1995 Jan; 12(1):22-4. PubMed ID: 7710570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin use in a Jehovah's Witness patient.
    Walton T; Macon EJ
    Ann Pharmacother; 2002 Apr; 36(4):729-30. PubMed ID: 11936087
    [No Abstract]   [Full Text] [Related]  

  • 31. Recombinant erythropoietin in clinical practice.
    Ng T; Marx G; Littlewood T; Macdougall I
    Postgrad Med J; 2003 Jul; 79(933):367-76. PubMed ID: 12897214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bone marrow amyloidosis with erythropoietin-resistant anemia in a patient undergoing chronic hemodialysis treatment.
    Cetinkaya R; Odabas AR; Selcuk Y; Erman Z; Kaya H
    South Med J; 2003 May; 96(5):491-3. PubMed ID: 12911189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recombinant human erythropoietin in patients with anemia due to end-stage renal disease. US multicenter trials.
    Sobota JT
    Contrib Nephrol; 1989; 76():166-78; discussion 212-8. PubMed ID: 2684519
    [No Abstract]   [Full Text] [Related]  

  • 34. Use of recombinant erythropoietin in a pregnant renal transplant recipient.
    Thorp M; Pulliam J
    Am J Nephrol; 1998; 18(5):448-51. PubMed ID: 9730574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Is the index of response to erythropoietin (IRE) a good marker of adequate dialysis?].
    Pérez-García R; Rodríguez-Benítez P; Villaverde MT; Valderrábano F
    Nefrologia; 2001; 21(6):606-7. PubMed ID: 11881433
    [No Abstract]   [Full Text] [Related]  

  • 36. Recombinant human erythropoietin in renal transplant recipients with renal anemia.
    Traindl O; Barnas U; Franz M; Falger S; Klauser R; Kovarik J; Graf H
    Clin Transplant; 1994 Feb; 8(1):45-8. PubMed ID: 8136567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Selected research topics.
    Am J Kidney Dis; 1991 Nov; 18(5 Suppl 2):96-104. PubMed ID: 1951363
    [No Abstract]   [Full Text] [Related]  

  • 38. [Recurrence of anemia after discontinuation of erythropoietin substitution].
    Jelkmann W
    Dtsch Med Wochenschr; 1991 Jul; 116(28-29):1127. PubMed ID: 2065604
    [No Abstract]   [Full Text] [Related]  

  • 39. Regression of left ventricular hypertrophy in dialysis patients following correction of anemia with recombinant human erythropoietin.
    Silberberg J; Racine N; Barre P; Sniderman AD
    Can J Cardiol; 1990; 6(1):1-4. PubMed ID: 2138048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. USA multicenter clinical trial with recombinant human erythropoietin (Amgen). Results in hemodialysis patients.
    Eschbach JW; Downing MR; Egrie JC; Browne JK; Adamson JW
    Contrib Nephrol; 1989; 76():160-5; discussion 212-8. PubMed ID: 2684518
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.